Heron Therapeutics Inc
HRTX
Log in to follow and get free email alerts when insiders file.
Sector
Pharmaceutical Preparations
Industry
Drugs
Website
Recent Filings - SEC Insider Transactions (Form 3,4,5)
File Date | Date | Company | Filer | Security | Shares | Price | $ Total | % Change | 10% | Dir. | Off. | Code | View | SEC | SIC | SIC Group | SIC Division |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buy / Sell (dollars)
1 Month
0%100%
$0.00
avg. $0.00
$3,075.00
avg. $3,075.00
Buy/Sell Ratio
0
Transactions
1
Filers
1
3 Month
65.7%34.3%
$69,337.00
avg. $69,337.00
$36,141.44
avg. $12,047.15
Buy/Sell Ratio
1.918
Transactions
15
Filers
6
12 Month
36.2%63.8%
$212,845.01
avg. $212,845.01
$374,686.37
avg. $31,223.86
Buy/Sell Ratio
0.568
Transactions
36
Filers
26
24 Month
41.6%58.4%
$723,729.55
avg. $723,729.55
$1.01M
avg. $42,285.98
Buy/Sell Ratio
0.713
Transactions
44
Filers
42
Filers
CIK | Name | Title | Last Transaction | First Transaction | Director | Officer | 10% Own. | Other |
---|---|---|---|---|---|---|---|---|
1370348 | Johnson Craig A | 2021-09-23 | 2019-12-23 | |||||
1384243 | Quart Barry D | Chief Executive Officer | 2021-07-15 | 2019-10-04 | ||||
1286100 | POYHONEN JOHN | EVP, Chief Commercial Officer | 2021-07-15 | 2019-10-04 | ||||
1202094 | MANHARD KIMBERLY | Executive VP, Drug Development | 2021-07-15 | 2019-12-03 | ||||
1828266 | Peraza Lisa | VP, Chief Accounting Officer | 2021-07-15 | 2020-10-15 | ||||
1602459 | Szekeres David Leslie | EVP, Chief Operating Officer | 2021-07-15 | 2020-10-20 | ||||
1553179 | Christian Waage | 2021-06-22 | 2019-12-23 | |||||
1131146 | DAVIS STEPHEN | 2020-12-23 | 2019-10-01 | |||||
1166288 | HOFFMAN ROBERT | CFO & SVP, Finance | 2019-12-23 | 2019-12-23 | ||||